Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Breast J ; 24(1): 51-54, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-28557131

RESUMEN

Tuberous breast deformity is a pathologic condition of the breast consisting of a constricting ring at the breast base, reduction in the volume of the breast parenchyma, and herniation of breast tissue through the nipple-areola complex with areola enlargement. This pathology is generally congenital and has an unknown etiopathogenesis. We report the first observation of tuberous breast deformity in consanguineous. This report suggests the potential role of a genetic base in the development of this deformity. Between May 2008 and March 2011, we observed six female patients from two different families, aged between 18 and 55 years, affected by tuberous breast deformity. The breast deformity was characterized by breast asymmetry in all six cases. Four patients underwent surgery to correct the deformity. Standardized objective measurements of breast and chest were taken. A Visual Analog Scale was used to evaluate patients' and physicians' satisfaction. The first three patients were consanguineous; two were first cousins, and the third was second cousin with one of the above. The other three patients were also from the same family: two sisters and their mother. According to Von Heimburg's classification, the patients presented different degrees of breast deformity. In all operated cases, a good esthetic result with a high satisfaction (average visual analog scale score 9) was achieved. The results remained stable over time and no revisions were needed after the 1-year follow-up. The possibility of a parental consanguinity for breast deformities such tuberous breast has never been described in the literature. This report suggests the possible genetic role in the development of tuberous breast deformity. Further studies and genetic tests are required to prove this hypothesis.


Asunto(s)
Enfermedades de la Mama/genética , Mama/anomalías , Consanguinidad , Adolescente , Adulto , Mama/cirugía , Enfermedades de la Mama/cirugía , Femenino , Predisposición Genética a la Enfermedad , Humanos , Mamoplastia/métodos , Persona de Mediana Edad , Adulto Joven
3.
Aesthetic Plast Surg ; 38(1): 192-198, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24337149

RESUMEN

BACKGROUND: Tuberous sclerosis, an autosomal dominant neurocutaneous syndrome seen in approximately 1 in 6,000 people worldwide, is characterized by the appearance of hamartomas in multiple organs. The classic clinical triad consists of angiofibromas, epilepsy, and developmental delay. Dermatologic disorder is one of the main characteristics. Angiofibromas, a common form of presentation, causes significant cosmetic and medical problems. The current treatment for skin lesions is laser therapy. The carbon dioxide (CO2) laser has been used satisfactorily in treating these lesions, but several studies have demonstrated a high percentage of recurrences. Erbium:yttrium-aluminum-garnet (YAG) laser treatment has been used to resurface skin abnormalities in patients with dermatologic conditions. The dye laser as an alternative uses the principles of selective photothermolysis and is very effective in treating the vascular component of tuberous sclerosis. The use of all these lasers to treat skin lesions in patients affected by tuberous sclerosis has never been described in the literature. METHODS: A retrospective study, conducted from 2007 to May 2013, investigated 13 patients who had tuberous sclerosis treated with an erbium:YAG/CO2/dye laser combination. RESULTS: All the patients showed great improvement of their skin lesions. The results were evident immediately after the first treatment. No patient experienced complications or recurrence. CONCLUSIONS: The combined use of the erbium:YAG/Dye/CO2 laser is a safe and effective treatment for skin lesions in patients affected by tuberous sclerosis. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .


Asunto(s)
Angiofibroma/cirugía , Láseres de Colorantes/uso terapéutico , Láseres de Estado Sólido/uso terapéutico , Neoplasias Cutáneas/cirugía , Esclerosis Tuberosa/complicaciones , Adolescente , Adulto , Dióxido de Carbono , Femenino , Humanos , Masculino , Inducción de Remisión , Estudios Retrospectivos , Adulto Joven
4.
J Cutan Med Surg ; 15(1): 21-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21291652

RESUMEN

BACKGROUND: A glomus tumor is a biologically benign neoplasm. The traditional surgical approach to treat this tumor boasts the lowest recurrence rates but may cause nail deformities. OBJECTIVE: A short-scar surgical approach was applied, with the aim of preserving the aesthetics of the nail. METHODS: Between January 1999 and January 2009, 25 patients who underwent surgery for a glomus tumor were included in the study. All patients underwent radical resection with three different surgical approaches based on the location of the tumor. RESULTS: All patients who were operated on had complete regression of pain immediately after surgery and at postsurgery follow-ups. CONCLUSION: The treatment of glomus tumors consists of surgical excision, which is successful if properly executed. Excision of sensitive afferent nervous fibers is a prerequisite to achieve regression of pain. A short-scar surgical approach ensures complete eradication of the tumor and preservation of nail aesthetics.


Asunto(s)
Dedos , Tumor Glómico/cirugía , Adulto , Cicatriz/prevención & control , Disección/métodos , Femenino , Tumor Glómico/patología , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Operativos/métodos
5.
Aesthetic Plast Surg ; 35(4): 439-45, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21072515

RESUMEN

BACKGROUND: Gynecomastia refers to a benign enlargement of the male breast. This article describes the authors' method of using power-assisted liposuction and gland removal through a subareolar incision for thin patients. METHODS: Power-assisted liposuction is performed for removal of fatty breast tissue in the chest area to allow skin retraction. The subareolar incision is used to remove glandular tissue from a male subject considered to be within a normal weight range but who has bilateral grade 1 or 2 gynecomastia. RESULTS: Gynecomastia correction was successfully performed for all the patients. The average volume of aspirated fat breast was 100-200 ml on each side. Each breast had 5-80 g of breast tissue removed. At the 3-month, 6-month, and 1-year follow-up assessments, all the treated patients were satisfied with their aesthetic results. CONCLUSIONS: Liposuction has the advantages of reducing the fat tissue where necessary to allow skin retraction and of reducing the traces left by surgery. The combination of surgical excision and power-assisted lipoplasty also is a valid choice for the treatment of thin patients.


Asunto(s)
Ginecomastia/cirugía , Adolescente , Adulto , Humanos , Lipectomía , Masculino , Mamoplastia , Delgadez , Adulto Joven
6.
Plast Surg Int ; 2010: 343820, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-22567229

RESUMEN

Introduction. The hypothenar hammer syndrome is a rare traumatic vascular disease of the hand. Method and Materials. We report the case of a 43-years-old man with a painful tumefaction of the left hypothenar region. The ulnar artery appeared thrombosed clinically and radiologically. The patient underwent surgery to resolve the ulnar nerve compression and revascularise the artery. Results. The symptoms disappeared immediately after surgery. The arterial flow was reestablished. Postoperatively on day 20, a new thrombosis of the ulnar artery occurred. Conclusion. Hypothenar hammer syndrome is caused by repetitive trauma to the heel of the hand. The alterations of the vessel due to its chronic inflammation caused an acute compression of the ulnar nerve at the Guyon's canal and, in our case, do not allow a permanent revascularisation of the ulnar artery.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...